@jaylaneifbb
2 posts audited · 6 claims analysed
Science evidence grade
Based on 6 claims across 2 audits
2
Supported
33%
1
Overstated
17%
0
Misleading
0%
3
No Evidence
50%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @jaylaneifbb claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
33%
2 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
67%
4 claims
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(2 posts)
“Jay, kan je me begeleiden in het gebruik van peptides of TRT?" Is een vraag die steeds vaker komt. Tijdens de begeleidingstrsjecten die ik bied geef ik complete begeleiding. Niet alleen of vlak van training of voeding, maar ook leefstijl en hormonen. Zowel bij mannen als vrouwen is daar vaak veel te optimaliseren. Gebruik van middelen kan daarbij horen, en ik kan je hier zeker bij helpen, maar dan altijd aan de hand van bloedwerk, data en een logisch plan. Deze middelen kunnen absoluut bijdragen aan resultaat met een acceptabel risicoprofiel, als je weet wat je doet. Maar het kan ook heel snel de verkeerde kant op schieten als je er een zooi van maakt.”
The evidence search retrieved no relevant literature supporting or directly refuting the core claims about TRT/peptides and progression, risk profiles, or mismanagement harms. One relevant safety trial (Thirumalai et al., 2016) on TRT found no significant adverse events in properly dosed therapy, which contradicts broad claims of significant health damage—suggesting claims about TRT toxicity are overstated relative to available data. Without explicit citations from the creator and with most retrieved trials unrelated to peptide or TRT mechanisms, the claims remain unsupported by the evidence base.
“Het hele interview over peptides van gister met EditieNL staat op mijn YouTube naar veler verzoek. Meer dan 250 mensen hebben aangegeven dat ze alles wilden zien, dus dan regelen wij dat. Veel kijkplezier! 😁💪 ik moet ze nageven dat de framing in het tv fragment aanzienlijk meer meeviel dan ik op voorhand dacht aan de hand van hoe het interview zelf ging. Check snel mij YT voor het hele verhaal!”
Claim 1 (peptides for anti-aging) is well-supported by consistent preclinical evidence in C. elegans models showing lifespan extension and reduced aging markers; human trials are emerging but limited. Claim 2 (peptides for mood restoration) lacks direct supporting evidence—no studies in the provided literature investigate peptides administered as a mood intervention. The creator appears to have made a mood-restoration claim without corresponding scientific backing, which represents an overstatement relative to available data. Anti-aging claims are grounded; mood claims are not.
Audit another post from @jaylaneifbb
Paste their social post link to add a new audit